Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Fraud of Biological Psychiatry -- Ignore unavailable to you. Want to Upgrade?

To: AugustWest who wrote (299)	1/16/2002 7:36:41 AM
From: AugustWest	Read Replies (1) \| Respond to of 444

Side effects of drugs prescribed for psychological and psychiatric disorders METADATE CD (methylphenidate HCI) Used to treat: attention deficit hyperactivity disorder. Extended release capsules of methylphenidate hydrochloride means once-daily dose. For patients six years and older. Action: central nervous system stimulant Side effects: * headache * stomach ache * loss of appetite * insomnia Warnings * "Sufficient data on the safety of long-term use of methylphenidate in children are not yet available. Although a causal relationship has not been established, s uppression of growth has been reported with the long-term use of stimulants in children." * "Should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and psychology dependence with varying degrees of abnormal behavior." Manufacturer: Eurand American Inc.; marketed by Celltech Pharmaceuticals, Rochester, NY. Eurand supplies the extended-release technology, called Diffucaps, and is the sole manufacturer. Diffucaps is a bead delivery system; each bead, acting as a drug reservoir, is coated with a polymer that has a specific release profile. History: Approved by the FDA April 2001. mindful-things.com